The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Transcatheter Tricuspid Valve Repair with the Modified TriClip/MitraClip G4 System

DOI: 10.4244/EIJ-D-20-01295

1. Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
2. Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention and external reviewers - has been published immediately upon acceptance as it was received in the last round of revision. The content of this article is the responsibility of the authors.

Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.

To read the full content of this article, please log in to download the PDF.

A 57-year-old woman presented with progressive New York Heart Association (NYHA) class III dyspnea, edema and fatigue. Past history included hypertrophic cardiomyopathy with recent implantable cardioverter-defibrillator (ICD) lead extraction due to high impedance, followed by subcutaneous ICD implantation. Echocardiography subsequently demonstrated torrential tricuspid regurgitation (TR) with posterior leaflet flail and a 15 mm flail gap (Figure 1A-1C, Moving Images 1-3). The right ventricle (RV) was dilated with normal function, left ventricular (LV) function was preserved with normal pulmonary pressures. After Heart Team review, the patient underwent transcatheter tricuspid valve repair (TTVr) with the modified TriClip/MitraClip G4 system (Abbott, Santa Clara, USA).

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)